Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, PR China.
Ren Fail. 2023 Dec;45(1):2194439. doi: 10.1080/0886022X.2023.2194439.
Little is known about the effect of visit-to-visit ultrafiltration volume (UV) variability on the outcome. In this study, we investigated the association between visit-to-visit UV variability and all-cause mortality in patients receiving hemodialysis (HD).
We consecutively enrolled patients who received maintenance HD in our center from March 2015 to March 2021. UV variability was defined using standard deviation (UVSD) and coefficient of variation (UVCV) (standard deviation divided by the mean). The relationship between UV variability and all-cause mortality was assessed using univariate and multivariate Cox proportional hazard regression models. Receiver operating characteristic curves were used to evaluate the predictive abilities of UVSD and UVCV for short-term and long-term survival rates.
A total of 283 HD patients were included. The mean age was 57.54 years, and 53% were males. Follow-up was done for a median of 3.38 years (IQR 1.83-4.78). During the follow-up period, 73 patients died. Cox proportional hazards models indicated that UVSD and UVCV (higher versus lower) were positively associated with all-cause mortality (=.003 and <.001, respectively), while in multivariable-adjusted models, only higher UVCV remained significantly associated with all-cause mortality in patients receiving HD (HR 2.55 (95% CI 1.397-4.654), =.002). Moreover, subgroup analyses showed that the predictive performance of UVCV was more accurate among older patients, males and patients with comorbidities.
Visit-to-visit UV variability, especially UVCV, is a helpful indicator for predicting all-cause mortality in patients receiving HD, especially for older patients, males and those with comorbidities.
关于超滤量(UV)变异性对预后的影响知之甚少。本研究旨在探讨接受血液透析(HD)患者的随访间 UV 变异性与全因死亡率之间的关系。
我们连续纳入了 2015 年 3 月至 2021 年 3 月在我院接受维持性 HD 的患者。采用标准差(UVSD)和变异系数(UVCV)(标准差除以平均值)来定义 UV 变异性。使用单变量和多变量 Cox 比例风险回归模型评估 UV 变异性与全因死亡率之间的关系。使用受试者工作特征曲线评估 UVSD 和 UVCV 对短期和长期生存率的预测能力。
共纳入 283 例 HD 患者,平均年龄为 57.54 岁,53%为男性。中位随访时间为 3.38 年(IQR 1.83-4.78)。随访期间,73 例患者死亡。Cox 比例风险模型表明,UVSD 和 UVCV(较高 vs 较低)与全因死亡率呈正相关(分别为<.001 和.003),而在多变量调整模型中,只有较高的 UVCV 与接受 HD 的患者的全因死亡率仍显著相关(HR 2.55(95%CI 1.397-4.654),<.001)。此外,亚组分析显示,在老年患者、男性和合并症患者中,UVCV 的预测性能更为准确。
随访间 UV 变异性,尤其是 UVCV,是预测接受 HD 患者全因死亡率的有用指标,特别是对于老年患者、男性和合并症患者。